A senior National Institutes of Health official presented the “Make America Healthy Again” (MAHA) initiative at the American Diabetes Association’s 2026 Scientific Sessions in New Orleans, seeking to demonstrate alignment with established NIH research priorities. Richard Woychik addressed the diabetes research community, arguing that the controversial health strategy supports federal efforts to combat chronic disease. The presentation occurs as diabetes affects an estimated 37.3 million Americans, representing a significant public health burden that intersects with MAHA’s stated objectives. However, the diabetes research community received the presentation with measured skepticism, reflecting broader academic concerns about political health initiatives potentially influencing scientific independence and federal research funding allocations.
Was this article helpful?
